Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Measurable concentrations exist in human blood plasma, and those concentrations respond to physiological states
others classify it more strictly
Fibroblast activity increases in BPC-157-treated tissue, driving faster extracellular matrix deposition that forms the structural foundation of repaired tendons
Think of it as a catalyst: it initiates healing cascades at the cellular level, and those cascades keep working even once the peptide has cleared your system
Serrao may prescribe these injections to treat or prevent vitamin B12 deficiency
US$ 27.48
US$ 29.51
US$ 21.76
US$ 20.73
US$ 27.05
